Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 USD | -1.10% | -6.57% | +15.88% |
May. 09 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q1 Revenue $98,000 | MT |
May. 09 | VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.88% | 38.07M | |
+37.78% | 723B | |
+31.24% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.04% | 244B | |
+9.67% | 210B | |
-4.99% | 208B | |
+9.32% | 169B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Vyne Therapeutics Says Vitiligo Drug Candidate Has No Negative Effect on Platelet Count in Phase 1a Trial; Shares Rise